# Labrys Biologics, Inc. — Form D

Labrys Biologics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-28. The offering totals $31.0M, of which $14.6M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2012-12-28
- Form: D
- Accession: 0001140361-12-053041
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $31.0M
- Amount sold: $14.6M
- Remaining: $16.4M
- Investors: 5
- Date of first sale: 2012-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-189143

## Issuer

- Name: Labrys Biologics, Inc.
- CIK: 0001564179
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1700 OWENS STREET, SAN FRANCISCO, CA, 94158
- Phone: 415-800-0800

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Corey Goodman | Director | Cambridge, MA |
| Wende Hutton | Director | Menlo Park, CA |
| Steve P James | Director | San Francisco, CA |
| Nina S Kjellson | Director | Palo Alto, CA |
| Michael F Powell | Director | Palo Alto, CA |
| Robert P Adelman | Executive Officer | San Francisco, CA |
| Corey Goodman | Executive Officer | Cambridge, MA |
| Steve P James | Executive Officer | San Francisco, CA |
| Steve P James | Promoter | San Francisco, CA |

## More

- [CIK 1564179 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1564179&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-12-053041.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.